Literature DB >> 33152446

Prenatal exposure to viral infection and neuropsychiatric disorders in offspring: A review of the literature and recommendations for the COVID-19 pandemic.

Anna Zimmer1, Alix Youngblood1, Adam Adnane1, Brian J Miller2, David R Goldsmith3.   

Abstract

The SARS-CoV-2 virus has emerged as a striking 21st century pandemic. Communities across the globe have experienced significant infection rates and widespread psychosocial stress and trauma, leading to calls for increased allocation of resources for mental health screening and treatment. In addition to the burden of psychosocial stress, there is increasing evidence of direct viral neuroinvasion of the central nervous system through physical contact with the nasal mucosa. In a parallel fashion, there is a significant body of ongoing research related to the risk of in utero viral transmission and the resulting neurodevelopmental impact in the fetus. Aberrant neurodevelopment secondary to viral transmission has previously been related to the later development of psychosis, schizophrenia, and schizophrenia spectrum disorders, generating the hypothesis that this population of individuals exposed to SARS-CoV-2 may see an increased incidence in future decades. We discuss the current understanding of the possible neurotropism and vertical transmission of SARS-CoV-2, and relate this to the history of viral pandemics to better understand the relationship of viral infection, aberrant immune response and neurodevelopment, and the risk for schizophrenia disorder.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Infection; Neurodevelopment; Pre-natal exposure; SARS-CoV-2; Schizophrenia risk

Year:  2020        PMID: 33152446     DOI: 10.1016/j.bbi.2020.10.024

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  8 in total

Review 1.  Schizophrenia during the COVID-19 pandemic.

Authors:  Stefano Barlati; Gabriele Nibbio; Antonio Vita
Journal:  Curr Opin Psychiatry       Date:  2021-05-01       Impact factor: 4.787

Review 2.  [Consequences of the COVID-19 pandemic for people with schizophrenia, dementia and substance use disorders].

Authors:  Kristina Adorjan; Robert Haussmann; Katrin Rauen; Oliver Pogarell
Journal:  Nervenarzt       Date:  2021-03-29       Impact factor: 1.214

Review 3.  Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor.

Authors:  Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-01-05       Impact factor: 5.270

Review 4.  Emerging Knowledge of the Neurobiology of COVID-19.

Authors:  Matthew Butler; Benjamin Cross; Danish Hafeez; Mao Fong Lim; Hamilton Morrin; Emma Rachel Rengasamy; Tom Pollak; Timothy R Nicholson
Journal:  Psychiatr Clin North Am       Date:  2021-11-11

5.  Immune Signatures of Treatment-Resistant Schizophrenia: A FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Study.

Authors:  Marion Leboyer; Ophélia Godin; Emilie Terro; Wahid Boukouaci; Ching-Lieng Lu; Myrtille Andre; Bruno Aouizerate; Fabrice Berna; Caroline Barau; Delphine Capdevielle; Julie Clauss-Kobayashi; Isabelle Chereau; Thierry D Amato; Caroline Dubertret; Julien Dubreucq; Guillaume Fond; Hakim Laouamri; Sylvain Leignier; Christophe Lancon; Pierre-Michel Llorca; Jasmina Mallet; Philippe Le Corvoisier; David Misdrahi; Christine Passerieux; Romain Rey; Baptiste Pignon; Mathieu Urbach; Andrei Szoke; Franck Schürhoff; Ryad Tamouza
Journal:  Schizophr Bull Open       Date:  2021-04-27

Review 6.  New Insights Regarding Diagnosis and Medication for Schizophrenia Based on Neuronal Synapse-Microglia Interaction.

Authors:  Naotaka Izuo; Atsumi Nitta
Journal:  J Pers Med       Date:  2021-05-03

7.  Maternal immune activation as a risk factor for psychiatric illness in the context of the SARS-CoV-2 pandemic.

Authors:  Brittney Lins
Journal:  Brain Behav Immun Health       Date:  2021-07-15

8.  Virtual Reality and Wearable Technologies to Support Adaptive Responding of Children and Adolescents With Neurodevelopmental Disorders: A Critical Comment and New Perspectives.

Authors:  Fabrizio Stasolla
Journal:  Front Psychol       Date:  2021-07-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.